Sort   by:  
 Page size 
UnknownAn extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.
Not available
S-EPMC9797215 | biostudies-literature
UnknownTemporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.
Not available
S-EPMC8722583 | biostudies-literature
UnknownTemporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.
Not available
S-EPMC9189142 | biostudies-literature
UnknownA third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile.
Not available
S-EPMC9902290 | biostudies-literature
UnknownStrong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses.
Not available
S-EPMC8639412 | biostudies-literature
Sort   by:  
 Page size